| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
AIM ImmunoTech Inc. (LSE: 0A4Y)
0A4Y Technical Analysis
5
| As on 12th Apr 2022 0A4Y STOCK Price closed @ 0.95 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.98 & Strong Sell for SHORT-TERM with Stoploss of 2.30 we also expect STOCK to react on Following IMPORTANT LEVELS. |
0A4YSTOCK Price
| Open | 1.18 | Change | Price | % |
| High | 1.18 | 1 Day | -0.13 | -12.04 |
| Low | 0.95 | 1 Week | 0.00 | 0.00 |
| Close | 0.95 | 1 Month | -1.01 | -51.53 |
| Volume | 6009 | 1 Year | -1.34 | -58.52 |
| 52 Week High 2.91 | 52 Week Low 0.76 | ||||
LSE UK Most Active Stocks
| DKE | 0.15 | 0.00% |
| NNN | 0.09 | 50.00% |
| SYME | 0.10 | -9.09% |
| DMTR | 0.03 | 0.00% |
| PREM | 0.53 | 3.92% |
| MCLS | 1.68 | 46.09% |
| YGEN | 0.49 | 0.00% |
| CLON | 0.11 | 0.00% |
| VOD | 71.04 | 0.57% |
| BOIL | 0.10 | 0.00% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
| 0A4Y Daily Charts |
0A4Y Intraday Charts |
Whats New @ Bazaartrend |
0A4Y Free Analysis |
|
|
0A4Y Important Levels Intraday
| RESISTANCE | 1.39 |
| RESISTANCE | 1.25 |
| RESISTANCE | 1.16 |
| RESISTANCE | 1.08 |
| SUPPORT | 0.82 |
| SUPPORT | 0.74 |
| SUPPORT | 0.65 |
| SUPPORT | 0.51 |
0A4Y Forecast May 2024
| 4th UP Forecast | 2.99 |
| 3rd UP Forecast | 2.34 |
| 2nd UP Forecast | 1.93 |
| 1st UP Forecast | 1.53 |
| 1st DOWN Forecast | 0.37 |
| 2nd DOWN Forecast | -0.03 |
| 3rd DOWN Forecast | -0.44 |
| 4th DOWN Forecast | -1.09 |
0A4Y Weekly Forecast
| 4th UP Forecast | 2.51 |
| 3rd UP Forecast | 2.01 |
| 2nd UP Forecast | 1.70 |
| 1st UP Forecast | 1.39 |
| 1st DOWN Forecast | 0.51 |
| 2nd DOWN Forecast | 0.20 |
| 3rd DOWN Forecast | -0.11 |
| 4th DOWN Forecast | -0.61 |
0A4Y Forecast2024
| 4th UP Forecast | 5.34 |
| 3rd UP Forecast | 3.93 |
| 2nd UP Forecast | 3.06 |
| 1st UP Forecast | 2.19 |
| 1st DOWN Forecast | -0.29 |
| 2nd DOWN Forecast | -1.16 |
| 3rd DOWN Forecast | -2.03 |
| 4th DOWN Forecast | -3.44 |
AIM ImmunoTech Inc. ( LSE UK Symbol : 0A4Y )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
0A4Y Business Profile
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viruses, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic encephalomyelitis, Hepatitis B, and HIV. The company also provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with UMN Pharma Inc.; Japanese National Institute of Infectious Diseases; and Shionogi & Co., Ltd.; Polysciences Inc.; and University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1990 and is headquartered in Ocala, Florida. Address: 2117 SW Highway 484, Ocala, FL, United States, 34473
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service